Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research ; 25(7):S289-S290, 2022.
Article in English | EuropePMC | ID: covidwho-1904939
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research ; 25(7):S448-S449, 2022.
Article in English | EuropePMC | ID: covidwho-1904938
Article in English | Web of Science | ID: covidwho-1904487


Children with malignancies are facing new challenges in post-COVID-19 era. We report an interesting case of a child on treatment for acute lymphoblastic leukemia having a very protracted course of illness with complications not often seen with standard therapy. It intends to make pediatric oncologists and intensive care specialists wary of potential newer complications.

Evolving Multicultural Education for Global Classrooms ; : 40-67, 2021.
Article in English | Scopus | ID: covidwho-1810541


During the COVID-19 pandemic, there has been a dramatic surge in anti-Asian racism in the United States. Asians have been blamed for the pandemic. Multicultural education improves cross-cultural understanding and reduces discrimination. Parental racial socialization is an important facet of multicultural education as parents convey racial and ethnic messages to their children. Yet, little research has documented parental racial socialization in Asian families. To address this gap, the authors interviewed 19 Asians and Asian Americans during the COVID-19 pandemic. This chapter shows that discrimination experiences start at an early age and have a lasting impact. Discrimination of Asians is related to the perpetual foreigner stereotype and the model minority myth. These impede how Asians understand their racial discrimination experiences and how families discuss race and ethnicity. All parents in the study expressed how critical parental racial socialization was during the COVID-19 pandemic and suggest that schools are essential to supporting multicultural education at home. © 2021, IGI Global.

Value in Health ; 25(1):S31, 2022.
Article in English | EMBASE | ID: covidwho-1650260


Objectives: Oxygen therapy is critical in severe COVID-19 patients. Factors that impact the oxygen use in severe COVID-19 patients are important to understand. This study aims to identify the factors such as co-morbidities, length of stay, post-discharge oxygen use, and rehospitalization in COVID-19 patients with oxygen therapy. Methods: We identified hospitalized patients diagnosed with COVID-19 from 01 April 2020 to 31 December 2020 using Optum’s de-identified US administrative claims database. Index date was date of first inpatient COVID-19 diagnosis. Included patients had evidence of oxygen therapy during their hospital stay;pregnant patients were excluded. Patients were observed 12-months pre-index to capture demographics and comorbidities;and were observed for at least 3 months post-discharge to assess the outcomes. Results: A total of 104,456 hospitalized patients with COVID-19 were identified;16,492 (15.8%) had evidence of oxygen therapy use during hospitalization. Mean (SD) age was 68.8 (12.1) years, 48.3% were males. During baseline, the most frequent (top 5) comorbidities were hypertension (83.7%), other cardiovascular disease (69.5%), diabetes mellitus (52.2%), obesity (51.7%), and kidney disease (38.7%). Respiratory-related comorbidities such as COPD, other pulmonary disease, and asthma were found in 34.0%, 32.9%, and 16.0% of patients, respectively. Hospital length of stay was <7 days, 7-14 days and >14 days for 30.6%, 29.1%, and 17.8% of patients, respectively;5.0% of patients had evidence of home-based oxygen therapy after discharge. Overall, 28.3% of patients were rehospitalized within 60 days post-discharge regardless of their home-based oxygen use. Conclusions: Comorbidities were prevalent among hospitalized patients with COVID-19 using oxygen therapy;and rehospitalization was common. Further analysis is needed to understand the impact of comorbid conditions on rehospitalization in patients with severe COVID-19 requiring hospitalization and oxygen therapy. Evidence of oxygen therapy was low, suggesting oxygen use is under-reported in administrative claims data, future studies using EHR data may be appropriate.

Muscle & Nerve ; 64:S47-S47, 2021.
Article in English | Web of Science | ID: covidwho-1507236